Fatal strongyloidiasis in patients receiving corticosteroids.
D000328:Adult; D000636:Aminosalicylic Acids / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects*; D003907:Dexamethasone / Q000009:adverse effects*; D004039:Diet, Sodium-Restricted; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects*; D007421:Intestine, Small / Q000473:pathology; D007538:Isoniazid / Q000009:adverse effects*; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy; D011241:Prednisone / Q000009:adverse effects*; D013322:Strongyloidiasis / Q000209:etiology*
D000636:Aminosalicylic Acids; D006852:Hydrochlorothiazide; D003907:Dexamethasone; D003520:Cyclophosphamide; D007538:Isoniazid; D011241:Prednisone